Campomelic dysplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:140OMIM:114290Q87.1
Who is this for?
Show terms as
15Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Campomelic dysplasia (also known as campomelic syndrome or camptomelic dysplasia) is a rare, severe skeletal disorder caused by mutations in the SOX9 gene located on chromosome 17q24. The term 'campomelic' derives from the Greek words for 'bent limb,' reflecting one of the hallmark features of this condition — bowing of the long bones, particularly the tibiae and femora. The disorder affects multiple body systems including the skeletal system, respiratory system, and reproductive system. Key skeletal features include shortening and bowing of the lower limbs, hypoplastic scapulae, eleven pairs of ribs, a bell-shaped narrow thorax, cervical spine abnormalities, and talipes equinovarus (clubfoot). Craniofacial features include a flat face, micrognathia (small jaw), cleft palate, and a large head with a prominent forehead. A distinctive and clinically significant feature is that approximately two-thirds of 46,XY individuals with campomelic dysplasia exhibit sex reversal, presenting with female or ambiguous external genitalia due to the critical role of SOX9 in male sex determination. The condition is typically lethal in the neonatal period, with the majority of affected infants dying within the first weeks to months of life, primarily due to respiratory insufficiency caused by a small, poorly developed thoracic cage and tracheobronchomalacia (softening of the airway cartilage). However, long-term survival has been reported in a minority of cases, and these individuals may develop additional features including progressive kyphoscoliosis, short stature, hearing loss, and intellectual disability. There is no cure for campomelic dysplasia. Treatment is supportive and multidisciplinary, focusing on respiratory management (which may include tracheostomy and ventilatory support), orthopedic interventions for skeletal deformities, and appropriate management of sex development differences. Genetic counseling is important for affected families, as most cases arise from de novo (new) mutations, though rare instances of autosomal dominant inheritance from a mildly affected parent have been documented.

Also known as:

Clinical phenotype terms— hover any for plain English:

11 pairs of ribsHP:0000878TracheomalaciaHP:0002779TracheobronchomalaciaHP:0002786Tibial bowingHP:0002982Fibular hypoplasiaHP:0003038Small abnormally formed scapulaeHP:0006584Poorly ossified cervical vertebraeHP:0008477Hypoplastic inferior iliaHP:0008821
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Campomelic dysplasia.

View clinical trials →

No actively recruiting trials found for Campomelic dysplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Campomelic dysplasia community →

Specialists

15 foundView all specialists →
KN
Kaya Narimatsu
Specialist
1 Campomelic dysplasia publication
AI
Akihiko Iida
Specialist
1 Campomelic dysplasia publication
TK
Takanori Kobayashi
Specialist
1 Campomelic dysplasia publication
CG
Catherine Gestrich
PITTSBURGH, PA
Specialist
1 Campomelic dysplasia publication
NH
Nusrat Hossain
Specialist
1 Campomelic dysplasia publication
TI
Takeshi Igawa
Specialist
1 Campomelic dysplasia publication
MS
Makoto Suzuki
Specialist
1 Campomelic dysplasia publication
IT
Ichiro Tazawa
Specialist
1 Campomelic dysplasia publication
YN
Yuta Nakao
Specialist
1 Campomelic dysplasia publication
TH
Toshinori Hayashi
Specialist
1 Campomelic dysplasia publication
NS
Nanoka Suzuki
Specialist
1 Campomelic dysplasia publication
HO
Hajime Ogino
Specialist
1 Campomelic dysplasia publication
EE
Esther Elishaev
PITTSBURGH, PA
Specialist
1 Campomelic dysplasia publication
SW
Sarah Waszyn
SAN ANTONIO, TX
Specialist
1 Campomelic dysplasia publication
CT
Craig V Towers
KNOXVILLE, TN
Specialist
1 Campomelic dysplasia publication

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Campomelic dysplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Campomelic dysplasiaForum →

No community posts yet. Be the first to share your experience with Campomelic dysplasia.

Start the conversation →

Latest news about Campomelic dysplasia

No recent news articles for Campomelic dysplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Campomelic dysplasia

What is Campomelic dysplasia?

Campomelic dysplasia (also known as campomelic syndrome or camptomelic dysplasia) is a rare, severe skeletal disorder caused by mutations in the SOX9 gene located on chromosome 17q24. The term 'campomelic' derives from the Greek words for 'bent limb,' reflecting one of the hallmark features of this condition — bowing of the long bones, particularly the tibiae and femora. The disorder affects multiple body systems including the skeletal system, respiratory system, and reproductive system. Key skeletal features include shortening and bowing of the lower limbs, hypoplastic scapulae, eleven pairs

How is Campomelic dysplasia inherited?

Campomelic dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Campomelic dysplasia typically begin?

Typical onset of Campomelic dysplasia is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Campomelic dysplasia?

15 specialists and care centers treating Campomelic dysplasia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.